<?xml version="1.0" encoding="UTF-8"?>
<svg height="775.57" width="570.495" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(23,22,21);stroke-width:1.0;" d="M53.890 51.160 L558.110 51.160 "/>
  <g begin="text">
   <text y="48.203" x="189.318,193.638,197.382,201.297,205.275,209.019,211.179" svgx:width="0.48,0.42,0.44,0.44,0.42,0.24,0.24" style="fill:rgb(23,22,21);font-family:HeaveneticaCond4LtSH;font-size:9.0px;stroke:none;">Kanda, </text>
  </g>
  <g begin="text">
   <text y="48.203" x="213.338,217.145,219.224,221.384,225.128" svgx:width="0.42,0.23,0.24,0.42,0.18" style="fill:rgb(23,22,21);font-family:HeaveneticaCond4LtOblSH;font-size:9.0px;stroke:none;">et al</text>
  </g>
  <g begin="text">
   <text y="48.203" x="226.712,228.872,231.032,233.192,237.971,241.886,243.47,247.448,251.255,252.839,254.423,258.338,262.145,265.556,267.716,269.795,273.665,276.077,278.237,282.611,286.355,288.434,292.241,294.401,299.117,302.861,306.776,310.754,312.338,313.922,317.837,321.815,323.975,327.845,329.924,332.084,336.692,340.436,344.351,347.996,351.803,354.215,356.375,360.983,364.898,368.705,374.834,378.704,380.783,384.698,388.505,390.917,394.661,398.639,401.987,404.147,408.971,411.383,415.298,419.276" svgx:width="0.24,0.24,0.24,0.53,0.44,0.18,0.44,0.42,0.18,0.18,0.44,0.42,0.38,0.24,0.23,0.43,0.27,0.24,0.49,0.42,0.23,0.42,0.24,0.52,0.42,0.44,0.44,0.18,0.18,0.44,0.44,0.24,0.43,0.23,0.24,0.51,0.42,0.44,0.41,0.42,0.27,0.24,0.51,0.44,0.42,0.68,0.43,0.23,0.44,0.42,0.27,0.42,0.44,0.37,0.24,0.54,0.27,0.44,0.44,0.38" style="fill:rgb(23,22,21);font-family:HeaveneticaCond4LtSH;font-size:9.0px;stroke:none;">.: Guidelines for Safe Handling of Cancer Chemotherapy Drugs</text>
  </g>
  <g begin="text">
   <text y="757.918" x="264.715,269.638,273.328,274.966,279.07,281.527,286.45,290.554,294.244,295.882,299.572,303.262,305.314,309.004,313.108,317.212,319.669,323.773,327.877,329.515,331.567,335.671,337.723,339.775,345.517,349.621,353.311,357.415,359.053,363.157,367.261,370.951,373.003,378.331,382.435,384.892,388.582,390.22,394.324,398.428,400.48,403.064,405.116,409.656,413.76,415.398,419.502,425.649,429.753,431.805,435.909,437.961,440.544,442.596,444.648,448.338,452.028,456.132,460.236,462.288,466.392,468.444,471.027,473.079,478.821,482.511,484.563,488.667,492.771,496.875,499.332,501.789,507.117,511.221,514.911,519.015,525.162,529.266,533.37,535.827,537.879,541.983,546.087,550.191" svgx:width="0.55,0.41,0.18,0.46,0.27,0.55,0.46,0.41,0.18,0.41,0.41,0.23,0.41,0.46,0.46,0.27,0.46,0.46,0.18,0.23,0.46,0.23,0.23,0.64,0.46,0.41,0.46,0.18,0.46,0.46,0.41,0.23,0.59,0.46,0.27,0.41,0.18,0.46,0.46,0.23,0.29,0.23,0.55,0.46,0.18,0.46,0.68,0.46,0.23,0.46,0.23,0.29,0.23,0.23,0.41,0.41,0.46,0.46,0.23,0.46,0.23,0.29,0.23,0.64,0.41,0.23,0.46,0.46,0.46,0.27,0.27,0.59,0.46,0.41,0.46,0.68,0.46,0.46,0.27,0.23,0.46,0.46,0.46,0.46" style="fill:rgb(23,22,21);font-family:ArialNarrow;font-size:9.0px;stroke:none;">Asia‑Pacific Journal of Oncology Nursing • Volume 4 • Issue 4 • October‑December 2017</text>
  </g>
  <g begin="text">
   <text y="758.331" x="53.858,57.962,62.066" svgx:width="0.46,0.46,0.46" style="fill:rgb(23,22,21);font-family:ArialNarrow;font-size:9.0px;stroke:none;">312</text>
  </g>
  <path style="fill:none;stroke:rgb(23,22,21);stroke-width:0.25;" d="M557.740 743.950 L557.740 765.570 "/>
  <path style="fill:none;stroke:rgb(23,22,21);stroke-width:1.0;" d="M54.140 744.220 L558.240 744.220 "/>
  <g begin="text">
   <text y="67.686" x="72.338,78.857,83.022,87.188,92.202,96.368,99.648,102.334,106.992,109.083,115.169,117.498,119.584,126.103,131.246,134.527,138.25,142.415,146.138,148.229,155.097,157.783,160.588,165.747,167.838,172.853,177.018,180.299,187.762,191.978,194.664,196.755,200.773,205.44,210.455,215.045,218.768,223.91,227.191,231.356,233.447,236.252,240.842,242.933,247.149,252.292,255.097,257.783,262.925,267.09,271.68,276.695,279.381,283.597,287.32,290.125,292.811,297.001" svgx:width="0.77,0.49,0.49,0.59,0.49,0.39,0.32,0.55,0.27,0.72,0.27,0.27,0.77,0.61,0.39,0.44,0.49,0.44,0.27,0.81,0.32,0.33,0.61,0.27,0.59,0.49,0.39,0.88,0.5,0.32,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.27,0.33,0.54,0.27,0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Heederik D. Nurses with dermal exposure to antineoplastic </text>
  </g>
  <g begin="text">
   <text y="77.886" x="72.338,77.259,80.447,85.496,89.602,93.231,95.466,97.116,102.482,106.554,111.475,114.663,119.159,124.081,129.13,133.227,135.938,138.531,143.036,147.107,148.756,153.253,158.302,161.013,165.11,169.607,176.976,181.048,184.677,186.913,188.562,193.543,198.464,201.057,205.978,210.05,217.419,220.012,224.508,227.101,231.597,235.703,240.208,241.857,246.43,251.003,255.576,260.149,262.384,266.957,271.53,273.766,278.339,282.912,287.485,290.179,294.752" svgx:width="0.59,0.39,0.61,0.49,0.44,0.27,0.27,0.66,0.49,0.59,0.39,0.54,0.59,0.61,0.49,0.33,0.32,0.54,0.49,0.27,0.54,0.61,0.33,0.49,0.54,0.88,0.49,0.44,0.27,0.27,0.6,0.59,0.32,0.59,0.49,0.88,0.32,0.54,0.32,0.54,0.49,0.54,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">drugs: Reproductive outcomes. Epidemiology 2007;18:112‑9.</text>
  </g>
  <g begin="text">
   <text y="89.503" x="53.888,58.553,63.218,65.55,67.845,72.342,78.836,83.927,88.092,93.184,96.856,101.021,106.129,107.829,113.388,115.666,117.366,120.179,124.344,128.509,133.116,137.421,141.96,144.595,148.76,150.46,153.273,156.087,158.365,160.065,166.559,170.698,174.838,179.929,184.893,189.058,191.812,194.447,198.986,204.078,208.243,210.878,212.578,216.547,221.162,226.126,230.665,234.337,239.429,242.659,246.773,250.445,252.145,256.31,261.401,266.365,268.065,272.23,277.194,281.741,285.855,289.086,292.758,296.924" svgx:width="0.55,0.55,0.27,0.27,0.55,0.77,0.61,0.5,0.61,0.44,0.5,0.61,0.27,0.66,0.27,0.27,0.34,0.5,0.5,0.55,0.55,0.54,0.32,0.5,0.27,0.34,0.34,0.27,0.27,0.77,0.49,0.49,0.61,0.59,0.5,0.33,0.32,0.54,0.61,0.5,0.32,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.44,0.27,0.5,0.61,0.59,0.27,0.5,0.59,0.54,0.49,0.39,0.44,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">18. Quansah R, Jaakkola JJ. Occupational exposures and adverse </text>
  </g>
  <g begin="text">
   <text y="99.703" x="72.338,77.276,80.481,84.569,88.692,93.758,97.897,102.963,107.077,111.599,113.27,117.783,122.849,125.578,129.692,134.205,141.592,145.68,149.327,151.001,155.141,162.527,167.041,172.107,176.229,177.9,182.965,188.031,191.236,194.882,198.971,202.617,204.87,206.54,212.788,214.458,218.104,222.626,226.273,229.001,233.09,240.476,244.616,247.344,249.954,254.068,255.742,258.947,263.035,267.557,270.167,274.255,281.047,282.721,286.861,291.927,296.94" svgx:width="0.59,0.39,0.49,0.49,0.61,0.5,0.61,0.49,0.54,0.27,0.54,0.61,0.33,0.49,0.54,0.88,0.49,0.44,0.27,0.5,0.88,0.54,0.61,0.49,0.27,0.61,0.61,0.39,0.44,0.49,0.44,0.27,0.27,0.74,0.27,0.44,0.54,0.44,0.33,0.49,0.88,0.5,0.33,0.32,0.49,0.27,0.39,0.49,0.54,0.32,0.49,0.81,0.27,0.5,0.61,0.59,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">pregnancy outcomes among nurses: A systematic review and </text>
  </g>
  <g begin="text">
   <text y="109.903" x="72.338,79.742,83.847,86.592,90.749,93.478,97.634,102.717,106.874,109.5,114.039,117.703,120.329,123.993,126.262,127.945,130.75,132.433,139.989,144.519,151.923,156.028,161.111,164.775,166.458,172.918,177.023,181.18,183.806,186.552,191.652,193.335,196.089,200.959,205.116,208.337,212.468,217.568,224.972,227.717,230.471,232.154,236.761,241.368,245.975,250.582,252.852,257.459,262.066,264.335,268.942,273.549,278.156,282.763,285.492,290.099,294.706" svgx:width="0.88,0.49,0.33,0.5,0.33,0.5,0.61,0.5,0.32,0.54,0.44,0.32,0.44,0.27,0.27,0.34,0.27,0.99,0.54,0.88,0.49,0.61,0.44,0.27,0.77,0.49,0.5,0.32,0.33,0.61,0.27,0.33,0.58,0.5,0.39,0.49,0.61,0.88,0.33,0.33,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">meta‑analysis. J Womens Health (Larchmt) 2010;19:1851‑62.</text>
  </g>
  <g begin="text">
   <text y="121.521" x="53.888,58.555,63.221,65.55,67.845,72.341,77.271,81.488,88.355,92.078,96.669,101.811,103.571,109.291,115.011,117.34,119.1,124.561,129.151,133.342,138.501,142.666,145.352,149.517,153.733,158.876,160.64,166.361,174.232,176.561,178.316,186.714,191.874,196.039,198.725,202.941,208.083,209.843,214.917,221.241,223.57,225.33,230.26,232.946,237.544,240.23,245.245,249.835,252.64,255.326,257.086,263.605,266.291,271.068,275.233,278.514,281.319,283.079,288.153,294.673,297.002" svgx:width="0.55,0.55,0.27,0.27,0.55,0.58,0.5,0.81,0.44,0.54,0.61,0.27,0.67,0.67,0.27,0.27,0.66,0.54,0.49,0.61,0.49,0.32,0.49,0.5,0.61,0.27,0.67,0.93,0.27,0.27,0.99,0.61,0.49,0.32,0.5,0.61,0.27,0.6,0.74,0.27,0.27,0.58,0.32,0.54,0.32,0.59,0.54,0.33,0.32,0.27,0.77,0.32,0.56,0.49,0.39,0.33,0.27,0.6,0.77,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">19. Lawson CC, Rocheleau CM, Whelan EA, Lividoti Hibert EN, </text>
  </g>
  <g begin="text">
   <text y="131.721" x="72.338,78.415,81.696,85.912,88.25,92.415,99.283,103.006,107.664,110.35,113.138,118.612,120.941,123.724,128.866,133.881,136.567,140.732,144.931,149.096,151.782,159.245,163.461,168.604,171.392,177.478,179.807" svgx:width="0.71,0.39,0.5,0.28,0.49,0.81,0.44,0.55,0.32,0.27,0.64,0.27,0.27,0.61,0.59,0.32,0.49,0.49,0.49,0.32,0.88,0.5,0.61,0.27,0.72,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Grajewski B, Spiegelman D, </text>
  </g>
  <g begin="text">
   <text y="131.721" x="182.583,186.731,189.272,192.052,196.872" svgx:width="0.49,0.3,0.27,0.57,0.29" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Italic;font-size:8.5px;stroke:none;">et al</text>
  </g>
  <g begin="text">
   <text y="131.721" x="199.353,201.682,204.466,211.011,215.201,219.392,224.534,229.549,233.765,236.57,239.256,243.846,248.989,253.205,255.891,258.679,262.697,267.363,272.378,276.968,280.691,285.833,289.115,293.28,297.003" svgx:width="0.27,0.27,0.77,0.49,0.49,0.61,0.59,0.5,0.33,0.32,0.54,0.61,0.5,0.32,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.44,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">. Occupational exposures </text>
  </g>
  <g begin="text">
   <text y="141.921" x="72.338,76.52,83.949,88.505,93.613,97.778,99.487,104.595,109.704,112.951,116.64,120.771,124.46,126.168,130.35,135.459,140.435,142.143,145.39,148.038,151.727,156.346,158.055,162.611,165.382,167.09,170.779,175.756,180.312,185.42,188.191,192.373,197.482,201.613,206.169,211.277,214.966,216.675,220.857,225.6,230.156,233.403,236.174,238.826,243.382,248.49,250.785,252.494,258.784,266.208,267.917,270.743,272.452,278.963,283.706,287.395,290.166,294.297,297.103" svgx:width="0.5,0.88,0.54,0.61,0.49,0.27,0.61,0.61,0.39,0.44,0.49,0.44,0.27,0.5,0.61,0.59,0.27,0.39,0.32,0.44,0.55,0.27,0.54,0.33,0.27,0.44,0.59,0.54,0.61,0.33,0.5,0.61,0.49,0.54,0.61,0.44,0.27,0.5,0.56,0.54,0.39,0.33,0.32,0.54,0.61,0.27,0.27,0.74,0.88,0.27,0.34,0.27,0.77,0.56,0.44,0.33,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">among nurses and risk of spontaneous abortion. Am J Obstet </text>
  </g>
  <g begin="text">
   <text y="152.121" x="72.338,78.415,83.014,88.157,92.322,96.512,101.102,103.788,106.117,110.784,115.45,120.117,124.783,127.112,131.779,136.445,141.112,143.441,148.107,152.774,157.44,159.769,163.934,168.601,171.389,176.055" svgx:width="0.71,0.54,0.61,0.49,0.49,0.54,0.32,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.55,0.27,0.55,0.55,0.55,0.27,0.49,0.55,0.33,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Gynecol 2012;206:327.e1‑8.</text>
  </g>
  <g begin="text">
   <text y="163.738" x="53.888,58.553,63.218,65.55,67.845,72.342,77.731,82.142,86.112,90.081,93.014,98.403,103.307,105.602,107.047,112.3,115.411,117.987,120.282,121.727,126.973,130.5,134.963,140.369,144.831,150.22,152.515,153.96,157.071,159.647,161.94199999999998,163.387,169.354,174.19,179.035,184.424,188.836,191.131,192.576,195.687,203.116,205.691,207.986,209.431,215.138,219.55,224.811,230.2,234.637,237.689,240.621,245.458,250.847,253.142,254.587,257.519,262.908,265.20300000000003,266.648,272.037,277.426,280.954,284.005,288.468,292.905,297.071" svgx:width="0.55,0.55,0.27,0.27,0.55,0.61,0.49,0.44,0.44,0.32,0.61,0.55,0.27,0.55,0.59,0.34,0.27,0.27,0.55,0.66,0.39,0.5,0.61,0.5,0.61,0.27,0.55,0.34,0.27,0.27,0.55,0.67,0.54,0.54,0.61,0.49,0.27,0.55,0.34,0.99,0.27,0.27,0.55,0.66,0.49,0.59,0.61,0.49,0.33,0.32,0.54,0.61,0.27,0.55,0.32,0.61,0.27,0.55,0.61,0.61,0.39,0.33,0.5,0.49,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">20. Sessink PJ, Trahan J, Coyne JW. Reduction in Surface </text>
  </g>
  <g begin="text">
   <text y="173.938" x="72.338,78.058,82.648,87.791,90.596,94.812,102.275,104.961,110.104,114.32,117.125,119.811,124.4,129.543,131.846,139.778,142.464,145.269,150.428,152.732,158.452,163.051,167.241,169.927,174.517,179.532,184.692,189.282,193.005,198.02,203.179,207.395,214.858,217.544,222.559,226.724,229.028,231.714,236.856,239.16,243.826,248.493,250.796,257.316,262.458,264.762,271.281,275.871,279.594,284.609,287.295,290.1,294.316,297.002" svgx:width="0.67,0.54,0.61,0.33,0.5,0.88,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.99,0.32,0.33,0.61,0.27,0.67,0.54,0.49,0.32,0.54,0.59,0.61,0.54,0.44,0.59,0.61,0.5,0.88,0.32,0.59,0.49,0.27,0.32,0.61,0.27,0.55,0.55,0.27,0.77,0.61,0.27,0.77,0.54,0.44,0.59,0.32,0.33,0.5,0.32,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Contamination With Cyclophosphamide in 30 US Hospital </text>
  </g>
  <g begin="text">
   <text y="184.138" x="72.338,77.344,82.504,86.72,90.001,97.464,101.68,105.87,108.556,112.721,116.444,119.181,123.211,127.801,130.487,133.173,137.763,144.631,147.317,152.46,156.659,159.396,162.26,169.723,174.738,177.424,181.589,189.052,193.217,198.36,201.165,205.381,208.186,210.872,215.462,220.604,223.341,227.931,230.736,233.473,237.689,240.426,246.147,248.833,253.423,257.146,261.311,266.326,269.114,274.256,278.855,282.578,285.383,289.548,297.011" svgx:width="0.59,0.61,0.5,0.39,0.88,0.5,0.49,0.32,0.49,0.44,0.27,0.58,0.54,0.32,0.32,0.54,0.81,0.32,0.61,0.49,0.27,0.34,0.88,0.59,0.32,0.49,0.88,0.49,0.61,0.33,0.5,0.33,0.32,0.54,0.61,0.27,0.54,0.33,0.27,0.5,0.27,0.67,0.32,0.54,0.44,0.49,0.59,0.33,0.61,0.54,0.44,0.33,0.49,0.88,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Pharmacies Following Implementation of a Closed‑System </text>
  </g>
  <g begin="text">
   <text y="194.338" x="72.338,78.424,81.705,86.847,91.046,93.375,98.378,101.659,105.875,111.017,114.74,117.545,121.71,124.991,127.32,133.406,137.571,142.17,144.856,149.046,153.211,155.54,157.869,164.389,168.979,172.702,177.717,180.046,185.052,190.212,194.428,197.709,205.172,207.501,212.167,216.834,221.5,226.167,228.496,233.162,237.829,240.158,244.824,249.491,254.157,256.945,261.612,266.278" svgx:width="0.72,0.39,0.61,0.49,0.27,0.66,0.39,0.5,0.61,0.44,0.33,0.49,0.39,0.27,0.72,0.49,0.54,0.32,0.49,0.49,0.27,0.27,0.77,0.54,0.44,0.59,0.27,0.59,0.61,0.5,0.39,0.88,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Drug Transfer Device. Hosp Pharm 2013;48:204‑12.</text>
  </g>
  <g begin="text">
   <text y="205.955" x="53.888,58.555,63.221,65.55,67.845,72.341,77.484,81.649,85.372,89.095,91.781,96.924,101.581,104.191,109.197,112.062,114.391,117.0,122.721,127.311,132.453,137.596,142.186,145.467,148.076,153.695,160.214,162.543,165.153,168.017,172.607,175.741,179.94,184.105,189.247,192.97,197.56,202.703,205.312,208.027,214.351,216.68,219.289,223.813,228.412,231.098,235.263,238.544,241.153,246.772,252.849,255.178,257.788,263.249,267.414,272.429,277.571,281.762,284.567,287.253,291.843,296.985" svgx:width="0.55,0.55,0.27,0.27,0.55,0.61,0.49,0.44,0.44,0.32,0.61,0.55,0.27,0.59,0.34,0.27,0.27,0.67,0.54,0.61,0.61,0.54,0.39,0.27,0.66,0.77,0.27,0.27,0.34,0.54,0.39,0.49,0.49,0.61,0.44,0.54,0.61,0.27,0.34,0.74,0.27,0.27,0.66,0.54,0.32,0.49,0.39,0.27,0.66,0.71,0.27,0.27,0.66,0.49,0.59,0.61,0.49,0.33,0.32,0.54,0.61,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">21. Sessink PJ, Connor TH, Jorgenson JA, Tyler TG. Reduction </text>
  </g>
  <g begin="text">
   <text y="216.155" x="72.338,75.024,80.166,82.461,83.524,87.247,92.389,95.67,98.475,102.691,106.882,111.047,113.342,114.414,118.604,123.194,128.337,131.142,135.358,142.821,145.507,150.649,154.865,157.67,160.356,164.946,170.089,172.384,173.446,180.314,183.0,185.805,190.965,193.26,194.322,198.538,203.681,206.486,209.172,214.314,218.479,223.069,228.084,230.77,234.986,238.709,241.514,244.2,248.391,250.68599999999998,251.753,256.768,260.049,265.192,269.391,273.114,275.409,276.471,279.157,284.3,286.595,287.657,292.324,296.99" svgx:width="0.32,0.61,0.27,0.55,0.44,0.61,0.39,0.33,0.5,0.49,0.49,0.27,0.55,0.49,0.54,0.61,0.33,0.5,0.88,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.55,0.81,0.32,0.33,0.61,0.27,0.55,0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27,0.55,0.59,0.39,0.61,0.49,0.44,0.27,0.55,0.32,0.61,0.27,0.55,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">in surface contamination with antineoplastic drugs in 22 </text>
  </g>
  <g begin="text">
   <text y="226.355" x="72.338,77.497,82.087,85.81,90.825,93.511,96.316,100.532,103.218,105.126,110.141,115.3,119.516,122.797,130.26,134.476,138.667,141.353,145.518,149.241,151.153,153.839,158.982,160.889,163.694,168.854,173.019,174.931,181.451,186.593,188.506,191.311,195.901,198.587,201.273,205.863,212.731,215.417,220.559,224.758,226.671,229.357,236.82,241.835,244.521,248.686,256.149,260.314,265.456,268.261,272.477,275.282,277.968,282.558,287.701,289.613,294.203,297.008" svgx:width="0.61,0.54,0.44,0.59,0.32,0.33,0.5,0.32,0.27,0.59,0.61,0.5,0.39,0.88,0.5,0.49,0.32,0.49,0.44,0.27,0.32,0.61,0.27,0.33,0.61,0.49,0.27,0.77,0.61,0.27,0.33,0.54,0.32,0.32,0.54,0.81,0.32,0.61,0.49,0.27,0.32,0.88,0.59,0.32,0.49,0.88,0.49,0.61,0.33,0.5,0.33,0.32,0.54,0.61,0.27,0.54,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">hospital pharmacies in the US following implementation of </text>
  </g>
  <g begin="text">
   <text y="236.555" x="72.338,76.554,79.316,83.507,86.193,90.783,94.506,98.671,103.686,106.474,110.197,114.795,118.518,121.323,125.488,132.951,135.714,140.729,144.01,149.152,153.352,156.114,158.919,162.2,166.416,171.559,175.282,178.087,182.251,185.533,188.302,193.317,197.482,202.08,204.766,208.957,213.122,215.451,218.213,221.078,223.84,230.385,235.528,239.718,244.308,246.994,249.757,254.763,259.923,264.139,267.42,274.883,277.645,282.501,285.782,289.998,294.189,296.994" svgx:width="0.5,0.27,0.49,0.32,0.54,0.44,0.49,0.59,0.33,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.59,0.39,0.61,0.49,0.27,0.33,0.39,0.5,0.61,0.44,0.33,0.49,0.39,0.27,0.59,0.49,0.54,0.32,0.49,0.49,0.27,0.27,0.34,0.27,0.77,0.61,0.49,0.54,0.32,0.27,0.59,0.61,0.5,0.39,0.88,0.27,0.59,0.39,0.5,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">a closed‑system drug transfer device. J Oncol Pharm Pract </text>
  </g>
  <g begin="text">
   <text y="246.755" x="72.338,77.005,81.671,86.338,91.004,93.333,98.0,102.666,104.995,109.662,114.328,117.116,121.783,126.449" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2011;17:39‑48.</text>
  </g>
  <g begin="text">
   <text y="258.373" x="53.888,58.555,63.221,65.55,67.845,72.341,76.289,80.505,85.103,87.789,91.954,95.235,97.53,98.37,103.844,106.173,108.468,109.301,114.231,118.447,123.224,126.505,131.095,134.818,138.541,142.706,145.00099999999998,145.841,152.361,154.69,156.98499999999999,157.818,163.895,166.581,169.267,171.953,176.118,179.841,182.484,188.661,191.466,195.656,200.816,205.032,207.718,212.86,215.155,215.988,220.918,223.247,225.542,226.375,232.096,235.377,239.967,244.982,249.147,251.952,254.24699999999999,255.086,260.806,263.135,265.43,266.263,270.725,274.89,278.171,282.761,285.447,287.742,288.582,294.668,296.997" svgx:width="0.55,0.55,0.27,0.27,0.55,0.58,0.5,0.54,0.32,0.49,0.39,0.27,0.55,0.64,0.27,0.27,0.55,0.58,0.5,0.56,0.39,0.54,0.44,0.44,0.49,0.27,0.55,0.77,0.27,0.27,0.55,0.71,0.32,0.32,0.32,0.49,0.44,0.33,0.74,0.33,0.49,0.61,0.5,0.32,0.61,0.27,0.55,0.58,0.27,0.27,0.55,0.67,0.39,0.54,0.59,0.49,0.33,0.27,0.55,0.67,0.27,0.27,0.55,0.59,0.49,0.39,0.54,0.32,0.27,0.55,0.72,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">22. Favier B, Labrosse H, Gilles‑Afchain L, Cropet C, Perol D, </text>
  </g>
  <g begin="text">
   <text y="268.573" x="72.338,78.058,83.218,87.434,92.576,100.039,104.256,107.536,112.551,115.161,121.68,124.009" svgx:width="0.67,0.61,0.5,0.61,0.88,0.5,0.39,0.59,0.27,0.77,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Chaumard N, </text>
  </g>
  <g begin="text">
   <text y="268.573" x="126.618,130.766,133.307,135.917,140.736" svgx:width="0.49,0.3,0.27,0.57,0.29" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Italic;font-size:8.5px;stroke:none;">et al</text>
  </g>
  <g begin="text">
   <text y="268.573" x="143.214,145.543,148.152,153.771,158.93,163.095,165.705,170.711,175.871,180.087,183.81,187.975,192.191" svgx:width="0.27,0.27,0.66,0.61,0.49,0.27,0.59,0.61,0.5,0.44,0.49,0.5,0.32" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">. The Phaseal</text>
  </g>
  <g begin="text">
   <text y="265.742" x="194.879" svgx:width="0.82" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:4.96px;stroke:none;">®</text>
  </g>
  <g begin="text">
   <text y="268.573" x="198.951,201.56,205.283,209.882,213.605,216.41,220.575,228.038,230.367,232.976,235.841,243.304,248.319,252.535,256.725,259.53,262.14,266.73,269.535,272.144,274.83,277.635,281.358,283.968,289.11,292.833,296.998" svgx:width="0.27,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.27,0.34,0.88,0.59,0.5,0.49,0.33,0.27,0.54,0.33,0.27,0.32,0.33,0.44,0.27,0.61,0.44,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;"> system: Impact of its use </text>
  </g>
  <g begin="text">
   <text y="278.773" x="72.338,76.919,82.053,83.796,90.655,95.237,98.509,103.159,108.165,110.843,115.05,119.232,123.389,125.131,129.313,133.895,139.029,141.825,146.033,153.487,156.165,161.299,165.507,168.303,170.98,175.562,180.696,182.438,186.646,191.78,196.786,198.529,203.535,208.669,211.942,216.15,218.946,221.624,226.205,231.339,233.081,237.663,240.459,242.202,246.384,251.535,255.691,263.146,267.728,270.524,275.675,279.832,283.104,287.311,292.318,296.917" svgx:width="0.54,0.61,0.27,0.81,0.54,0.39,0.55,0.59,0.32,0.5,0.49,0.49,0.27,0.49,0.54,0.61,0.33,0.5,0.88,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.5,0.61,0.59,0.27,0.59,0.61,0.39,0.5,0.33,0.32,0.54,0.61,0.27,0.54,0.33,0.27,0.49,0.61,0.49,0.88,0.54,0.33,0.61,0.49,0.39,0.5,0.59,0.54,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">on workplace contamination and duration of chemotherapy </text>
  </g>
  <g begin="text">
   <text y="288.973" x="72.338,77.353,80.634,84.799,89.814,94.03,97.311,101.527,104.332,107.018,111.608,116.751,119.08,121.409,124.273,126.602,133.147,138.29,142.48,147.07,149.756,152.085,157.092,162.251,166.467,169.748,177.211,179.54,184.399,187.68,191.896,196.086,198.891,201.22,205.887,210.553,215.22,219.886,222.215,226.882,231.548,233.877,238.544,243.21,245.998,250.665,255.331" svgx:width="0.59,0.39,0.49,0.59,0.5,0.39,0.5,0.33,0.32,0.54,0.61,0.27,0.27,0.34,0.27,0.77,0.61,0.49,0.54,0.32,0.27,0.59,0.61,0.5,0.39,0.88,0.27,0.59,0.39,0.5,0.49,0.33,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">preparation. J Oncol Pharm Pract 2012;18:37‑45.</text>
  </g>
  <g begin="text">
   <text y="300.59" x="53.888,58.553,63.218,65.55,67.845,72.342,77.914,83.21,87.638,93.503,96.895,102.615,107.537,109.83200000000001,111.991,115.561,117.85600000000001,118.595,120.89,123.049,128.281,133.156,136.548,138.843,141.002,147.785,150.07999999999998,150.819,153.11399999999998,155.273,163.85,169.145,174.041,179.906,183.298,188.202,194.05,199.414,202.805,205.1,207.259,213.685,215.98,216.72,219.015,221.174,229.75,234.672,239.1,244.948,247.243,249.402,254.78,257.075,257.814,260.10900000000004,262.268,268.385,273.68,279.401,284.322,286.617,288.776,294.624,296.952" svgx:width="0.55,0.55,0.27,0.27,0.55,0.68,0.54,0.44,0.61,0.32,0.59,0.5,0.27,0.55,0.34,0.27,0.55,0.27,0.55,0.66,0.49,0.32,0.27,0.55,0.71,0.27,0.55,0.27,0.55,0.93,0.54,0.49,0.61,0.32,0.49,0.61,0.55,0.32,0.27,0.55,0.67,0.27,0.55,0.27,0.55,0.93,0.5,0.44,0.61,0.27,0.55,0.68,0.27,0.55,0.27,0.55,0.69,0.54,0.59,0.5,0.27,0.55,0.61,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">23. Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, </text>
  </g>
  <g begin="text">
   <text y="310.79" x="72.338,77.95,83.449,91.269,95.842,100.398,104.971,108.014,110.309,111.865,117.364,120.05,122.345,123.901,130.777,134.857,139.379,141.67399999999998,143.23,148.177,151.339,153.634,155.189,159.762,162.057,163.613,168.16,171.203,176.15,180.23,184.752,190.124,192.41899999999998,193.975,198.055,203.01,207.09,210.252,214.774,222.594,224.88899999999998,226.445,231.817,236.339,241.294,244.337,248.885,253.407,255.702,257.257,260.419,265.366,267.661,269.217,272.855,277.377,282.749,288.248,292.796,296.962" svgx:width="0.69,0.61,0.88,0.5,0.49,0.5,0.32,0.27,0.55,0.61,0.27,0.27,0.55,0.77,0.44,0.49,0.27,0.55,0.54,0.33,0.27,0.55,0.5,0.27,0.55,0.49,0.32,0.54,0.44,0.49,0.59,0.27,0.55,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.55,0.59,0.49,0.54,0.32,0.49,0.49,0.27,0.55,0.33,0.54,0.27,0.55,0.39,0.49,0.59,0.61,0.49,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Kumagai S. Use of a closed system device to reduce </text>
  </g>
  <g begin="text">
   <text y="320.99" x="72.338,76.928,81.118,85.309,90.451,95.466,99.682,102.487,105.173,109.763,114.906,119.122,121.808,123.627,127.817,132.407,137.55,140.355,144.571,152.034,154.72,159.862,164.078,166.883,169.569,174.159,179.302,181.117,185.333,190.475,195.49,197.303,201.321,205.988,211.003,215.593,219.316,224.458,227.739,231.904,233.723,236.528,241.118,242.933,247.149,252.291,255.096,257.782,262.925,267.09,271.68,276.695,279.381,283.597,287.32,290.125,292.811,297.001" svgx:width="0.54,0.49,0.49,0.61,0.59,0.5,0.33,0.32,0.54,0.61,0.5,0.32,0.27,0.49,0.54,0.61,0.33,0.5,0.88,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.5,0.61,0.59,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.27,0.33,0.54,0.27,0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">occupational contamination and exposure to antineoplastic </text>
  </g>
  <g begin="text">
   <text y="331.19" x="72.338,77.353,80.634,85.776,89.975,93.698,95.993,96.767,99.453,104.595,106.89,107.664,110.469,115.628,119.793,122.08800000000001,122.862,128.021,132.611,136.334,141.349,144.035,146.84,151.056,153.742,156.03699999999998,156.811,163.679,168.269,171.55,176.208,178.503,179.276,183.441,188.584,193.182,195.868,199.149,203.739,208.882,216.345,220.51,225.652,228.457,230.786,233.081,233.855,240.179,245.321,250.464,252.759,253.532,260.077,264.268,268.458,273.601,278.616,280.911,281.684,288.204,292.802,297.001" svgx:width="0.59,0.39,0.61,0.49,0.44,0.27,0.55,0.32,0.61,0.27,0.55,0.33,0.61,0.49,0.27,0.55,0.61,0.54,0.44,0.59,0.32,0.33,0.5,0.32,0.27,0.55,0.81,0.54,0.39,0.55,0.27,0.55,0.49,0.61,0.54,0.32,0.39,0.54,0.61,0.88,0.49,0.61,0.33,0.27,0.27,0.55,0.74,0.61,0.61,0.27,0.55,0.77,0.49,0.49,0.61,0.59,0.27,0.55,0.77,0.54,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">drugs in the hospital work environment. Ann Occup Hyg </text>
  </g>
  <g begin="text">
   <text y="341.39" x="72.338,77.005,81.671,86.338,91.004,93.333,98.0,102.666,104.995,109.662,114.328,118.995,121.783,126.449,131.116" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2009;53:153‑60.</text>
  </g>
  <g begin="text">
   <text y="353.007" x="53.888,58.553,63.218,65.55,67.845,72.342,80.464,83.341,87.727,92.575,94.87,96.258,102.169,104.688,106.983,108.372,113.706,116.582,120.994,128.057,131.972,136.757,142.091,144.386,145.775,153.834,160.549,163.07,165.36499999999998,166.754,169.808,174.59,177.915,182.309,186.67,192.003,195.917,200.703,206.036,208.331,209.72,212.626,219.145,221.665,223.95999999999998,225.349,230.064,234.854,237.73,242.091,245.567,247.862,249.251,254.377,259.71,262.23,264.52500000000003,265.914,272.629,276.543,279.419,284.753,289.148,291.44300000000004,292.832,297.048" svgx:width="0.55,0.55,0.27,0.27,0.55,0.99,0.32,0.49,0.55,0.27,0.55,0.67,0.27,0.27,0.55,0.61,0.32,0.5,0.81,0.44,0.54,0.61,0.27,0.55,0.93,0.77,0.27,0.27,0.55,0.34,0.54,0.39,0.49,0.49,0.61,0.44,0.54,0.61,0.27,0.55,0.34,0.74,0.27,0.27,0.55,0.66,0.54,0.32,0.49,0.39,0.27,0.55,0.58,0.61,0.27,0.27,0.55,0.77,0.44,0.32,0.61,0.49,0.27,0.55,0.5,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">24. Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a </text>
  </g>
  <g begin="text">
   <text y="363.207" x="72.338,76.911,79.979,84.952,89.057,93.605,99.002,102.173,106.278,111.259,115.365,118.552,123.1,130.945,133.23999999999998,134.822,140.219,143.883,148.855,152.043,156.59,161.163,164.351,167.419,172.4,176.948,179.243,180.824,186.221,190.769,195.75,198.818,203.391,207.939,210.23399999999998,211.815,215.002,219.975,222.26999999999998,223.851,227.514,232.062,237.459,242.984,247.557,252.105,254.39999999999998,255.981,261.378,265.926,269.589,273.695,278.667,284.192,289.717,294.265,296.951" svgx:width="0.49,0.32,0.54,0.44,0.49,0.59,0.33,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.55,0.59,0.39,0.54,0.33,0.49,0.49,0.33,0.32,0.54,0.49,0.27,0.55,0.59,0.49,0.54,0.32,0.49,0.49,0.27,0.55,0.33,0.54,0.27,0.55,0.39,0.49,0.59,0.61,0.49,0.49,0.27,0.55,0.59,0.49,0.39,0.44,0.54,0.61,0.61,0.49,0.32,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">closed‑system protective device to reduce personnel </text>
  </g>
  <g begin="text">
   <text y="373.407" x="72.338,76.356,81.022,86.037,90.627,94.35,99.493,102.774,106.939,109.242,112.047,116.637,118.941,123.157,128.299,131.104,133.79,138.933,143.098,147.688,152.703,155.389,159.605,163.328,166.133,168.819,173.009,175.313,179.529,183.728,187.893,193.035,195.84,199.563,201.892,204.196,210.52,217.983,220.286,223.151,225.454,231.974,236.139,240.355,243.041,245.846,251.005,253.309,258.451,263.05,266.773,269.578,271.881,276.888,282.047,286.263,289.544,297.007" svgx:width="0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.27,0.33,0.54,0.27,0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27,0.5,0.49,0.49,0.61,0.33,0.44,0.27,0.27,0.74,0.88,0.27,0.34,0.27,0.77,0.49,0.5,0.32,0.33,0.61,0.27,0.61,0.54,0.44,0.33,0.27,0.59,0.61,0.5,0.39,0.88,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">exposure to antineoplastic agents. Am J Health Syst Pharm </text>
  </g>
  <g begin="text">
   <text y="383.607" x="72.338,77.005,81.671,86.338,91.004,93.333,98.0,102.666,104.995,109.662,114.328,118.995,123.661,126.449,131.116,135.782" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2003;60:2314‑20.</text>
  </g>
  <g begin="text">
   <text y="67.686" x="315.0,319.665,324.33,326.662,328.957,333.453,339.488,343.603,345.303,351.275,356.367,360.039,364.158,369.25,370.95,375.829,378.107,379.807,385.842,389.956,393.974,397.204,401.318,403.953,406.707,410.872,414.544,416.244,421.268,424.614,426.892,428.592,433.471,436.106,438.86,441.614,444.249,448.363,451.117,455.656,460.748,462.448,467.327,469.605,471.305,476.038,481.129,484.801,487.555,490.19,494.797,496.497,504.317,506.595,508.295,513.174,517.288,521.453,525.911,530.076,534.224,538.339,540.039,542.793,546.023,550.562,558.025" svgx:width="0.55,0.55,0.27,0.27,0.55,0.72,0.49,0.27,0.74,0.61,0.44,0.49,0.61,0.27,0.58,0.27,0.27,0.72,0.49,0.58,0.39,0.49,0.32,0.33,0.5,0.44,0.27,0.6,0.58,0.27,0.27,0.58,0.32,0.33,0.33,0.32,0.49,0.33,0.54,0.61,0.27,0.58,0.27,0.27,0.58,0.61,0.44,0.33,0.32,0.55,0.27,0.93,0.27,0.27,0.58,0.49,0.5,0.55,0.5,0.49,0.49,0.27,0.33,0.39,0.54,0.88,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">25. De Ausen L, DeFreitas EF, Littleton L, Lustik M. Leakage from </text>
  </g>
  <g begin="text">
   <text y="77.886" x="333.45,337.641,340.327,344.917,348.639,352.805,357.82,360.608,364.331,368.929,372.652,375.457,379.622,387.085,389.48,392.285,395.566,399.782,404.925,408.648,411.453,415.618,418.899,421.293,426.308,430.473,435.072,437.758,441.948,446.113,449.836,452.23,456.446,460.169,462.557,467.572,471.737,474.542,478.707,482.898,485.703,489.868,494.883,497.279,502.056,506.655,509.043,513.259,515.648,518.929,523.145,528.16,530.846,535.436,539.652,543.842,546.647,549.333,553.932,558.096" svgx:width="0.49,0.32,0.54,0.44,0.49,0.59,0.33,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.33,0.39,0.5,0.61,0.44,0.33,0.49,0.39,0.27,0.59,0.49,0.54,0.32,0.49,0.49,0.44,0.27,0.5,0.44,0.27,0.59,0.49,0.33,0.49,0.49,0.33,0.49,0.59,0.27,0.56,0.54,0.27,0.5,0.27,0.39,0.5,0.59,0.32,0.54,0.5,0.49,0.33,0.32,0.54,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">closed‑system transfer devices as detected by a radioactive </text>
  </g>
  <g begin="text">
   <text y="88.086" x="333.45,336.255,339.536,343.752,347.943,352.108,354.854,357.183,359.512,365.836,373.299,375.628,378.492,380.821,387.341,391.506,395.722,398.408,401.213,406.372,408.701,413.844,418.442,422.165,424.97,427.299,432.306,437.465,441.681,444.962,452.425,454.754,459.421,464.087,468.754,473.421,475.75,480.416,485.083,487.412,492.078,496.745,501.411,504.199,508.866,513.532" svgx:width="0.33,0.39,0.5,0.49,0.49,0.39,0.27,0.27,0.74,0.88,0.27,0.34,0.27,0.77,0.49,0.5,0.32,0.33,0.61,0.27,0.61,0.54,0.44,0.33,0.27,0.59,0.61,0.5,0.39,0.88,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">tracer. Am J Health Syst Pharm 2013;70:619‑23.</text>
  </g>
  <g begin="text">
   <text y="99.703" x="315.0,319.667,324.333,326.662,328.957,333.453,339.973,342.659,346.382,351.542,354.228,358.427,362.643,367.301,369.987,372.191,377.801,380.13,382.335,387.743,392.333,397.475,402.618,407.208,409.413,414.487,416.816,419.022,424.165,429.307,433.506,436.192,440.791,445.007,448.73,453.872,456.076,463.947,466.276,468.479,473.343,477.933,483.076,487.241,494.704,499.846,503.127,507.343,509.553,517.424,519.753,521.956,528.501,531.306,535.029,540.172,544.679,548.895,551.101,555.787,558.116" svgx:width="0.55,0.55,0.27,0.27,0.55,0.77,0.32,0.44,0.61,0.32,0.49,0.5,0.55,0.32,0.27,0.66,0.27,0.27,0.69,0.54,0.61,0.61,0.54,0.27,0.6,0.27,0.27,0.61,0.61,0.49,0.32,0.54,0.5,0.44,0.61,0.27,0.93,0.27,0.27,0.68,0.54,0.61,0.49,0.88,0.61,0.39,0.5,0.27,0.93,0.27,0.27,0.77,0.33,0.44,0.61,0.55,0.5,0.27,0.66,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">26. Nishigaki R, Konno E, Sugiyasu M, Yonemura M, Otsuka T, </text>
  </g>
  <g begin="text">
   <text y="109.903" x="333.45,341.033,345.249,348.054,352.27,357.412,361.628,366.405,370.57,372.865,373.627,378.297,380.626,382.921,383.677,389.296,394.455,398.62,400.915,401.672,406.814,410.537,414.702,417.507,422.65,425.336,430.478,434.643,438.366,442.089,444.384,445.141,449.731,452.536,454.831,455.587,459.803,462.098,462.855,467.045,469.731,474.321,478.044,482.209,487.224,490.012,493.735,498.334,502.057,504.862,509.027,516.49,518.785,519.547,524.562,528.727,533.325,536.011,540.201,544.366,546.661,547.418,550.223,554.813,558.094" svgx:width="0.99,0.5,0.33,0.5,0.61,0.5,0.56,0.49,0.27,0.55,0.68,0.27,0.27,0.55,0.66,0.61,0.49,0.27,0.55,0.61,0.44,0.49,0.33,0.61,0.32,0.61,0.49,0.44,0.44,0.27,0.55,0.54,0.33,0.27,0.55,0.5,0.27,0.55,0.49,0.32,0.54,0.44,0.49,0.59,0.33,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.55,0.59,0.49,0.54,0.32,0.49,0.49,0.27,0.55,0.33,0.54,0.39,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Watanabe Y. The usefulness of a closed‑system device for </text>
  </g>
  <g begin="text">
   <text y="120.103" x="333.45,336.255,341.414,345.579,348.461,355.924,358.61,363.277,365.963,371.105,375.304,378.186,382.776,385.581,388.462,391.148,396.29,398.628,402.793,406.983,409.788,412.474,417.064,422.207,425.93,428.811,431.616,436.206,439.088,444.103,447.384,451.549,456.147,460.313,465.455,468.26,471.141,475.731,479.922,484.112,489.255,494.27,498.486,501.291,503.977,508.567,513.709,517.925,520.611,523.493,527.511,532.177,537.192,541.782,545.505,550.648,553.929,558.094" svgx:width="0.33,0.61,0.49,0.27,0.88,0.32,0.55,0.32,0.61,0.49,0.27,0.54,0.33,0.27,0.32,0.61,0.28,0.49,0.49,0.33,0.32,0.54,0.61,0.44,0.27,0.33,0.54,0.27,0.59,0.39,0.49,0.54,0.49,0.61,0.33,0.27,0.54,0.49,0.49,0.61,0.59,0.5,0.33,0.32,0.54,0.61,0.5,0.32,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">the mixing of injections to prevent occupational exposure </text>
  </g>
  <g begin="text">
   <text y="130.303" x="333.45,336.255,340.845,343.633,347.849,352.991,355.796,358.482,362.673,366.889,372.031,376.222,380.387,383.668,386.464,391.479,394.76,399.902,404.101,407.824,410.153,412.941,415.806,418.594,421.458,426.473,431.616,434.404,439.546,444.136,448.327,451.115,457.634,462.224,465.947,470.962,473.75,478.757,483.916,488.132,491.413,498.876,501.664,506.331,510.997,515.664,520.33,522.659,527.326,531.992,534.321,538.988,543.654,548.321,551.109,555.775" svgx:width="0.33,0.54,0.27,0.5,0.61,0.33,0.32,0.49,0.5,0.61,0.49,0.49,0.39,0.27,0.59,0.39,0.61,0.49,0.44,0.27,0.27,0.34,0.27,0.34,0.59,0.61,0.27,0.61,0.54,0.49,0.27,0.77,0.54,0.44,0.59,0.27,0.59,0.61,0.5,0.39,0.88,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">to anticancer drugs. J Jpn Soc Hosp Pharm 2010;46:113‑7.</text>
  </g>
  <g begin="text">
   <text y="140.503" x="333.45,336.264,338.95,344.092,346.421,349.286,353.502,358.517,362.733,367.875,372.04,375.763,379.928,382.742" svgx:width="0.33,0.32,0.61,0.27,0.34,0.5,0.59,0.5,0.61,0.49,0.44,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">(in Japanese).</text>
  </g>
  <g begin="text">
   <text y="152.121" x="315.0,319.665,324.33,326.662,328.957,333.453,338.732,343.084,346.025,350.751,353.046,354.38,357.381,359.846,362.141,363.475,371.482,376.208,379.625,382.447,384.742,386.077,394.084,396.549,398.844,400.178,405.567,410.846,418.445,422.797,427.132,431.484,434.306,436.601,437.935,445.942,448.407,450.702,452.037,458.692,463.044,467.687,472.039,476.773,481.125,488.724,493.076,495.37100000000004,496.706,501.984,504.449,506.744,508.079,512.916,517.268,524.867,529.219,534.498,538.824,544.12,546.942,549.237,550.571,555.85,558.179" svgx:width="0.55,0.55,0.27,0.27,0.55,0.61,0.5,0.33,0.54,0.27,0.55,0.34,0.27,0.27,0.55,0.93,0.54,0.39,0.32,0.27,0.55,0.93,0.27,0.27,0.55,0.69,0.61,0.88,0.5,0.49,0.5,0.32,0.27,0.55,0.93,0.27,0.27,0.55,0.77,0.5,0.55,0.5,0.54,0.5,0.88,0.5,0.27,0.55,0.61,0.27,0.27,0.55,0.68,0.5,0.88,0.5,0.61,0.49,0.61,0.32,0.27,0.55,0.61,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">27. Sato J, Mori M, Kumagai M, Nakayama S, Yamauchi S, </text>
  </g>
  <g begin="text">
   <text y="162.321" x="333.45,338.673,343.782,348.763,353.319,355.036,360.875,363.17" svgx:width="0.69,0.61,0.59,0.54,0.27,0.69,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Kudo K, </text>
  </g>
  <g begin="text">
   <text y="162.321" x="364.892,369.006,371.514,373.231,378.016" svgx:width="0.49,0.3,0.27,0.57,0.29" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Italic;font-size:8.5px;stroke:none;">et al</text>
  </g>
  <g begin="text">
   <text y="162.321" x="380.467,382.762,384.479,390.064,395.189,399.32,401.037,406.146,409.835,413.971,416.742,421.85,424.502,429.611,433.742,437.431,441.12,442.837,447.393,450.164,451.881,456.063,457.78,461.936,464.588,469.144,472.833,476.97,481.951,483.668,488.649,491.896,496.032,501.013,505.195,508.442,512.624,515.395,518.047,522.603,527.711,529.428,533.117,537.682,541.371,544.142,548.273,555.702,558.03" svgx:width="0.27,0.27,0.66,0.61,0.49,0.27,0.61,0.44,0.49,0.33,0.61,0.32,0.61,0.49,0.44,0.44,0.27,0.54,0.33,0.27,0.5,0.27,0.49,0.32,0.54,0.44,0.49,0.59,0.27,0.59,0.39,0.49,0.59,0.5,0.39,0.5,0.33,0.32,0.54,0.61,0.27,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">. The usefulness of a closed preparation system, </text>
  </g>
  <g begin="text">
   <text y="172.521" x="333.45,339.171,344.33,348.495,355.958,360.548,364.271,368.487,371.292" svgx:width="0.67,0.61,0.49,0.88,0.54,0.44,0.5,0.33,0.49" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Chemosafe</text>
  </g>
  <g begin="text">
   <text y="169.69" x="375.46" svgx:width="0.82" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:4.96px;stroke:none;">®</text>
  </g>
  <g begin="text">
   <text y="172.521" x="379.533,381.862,384.15700000000004,385.245,388.05,392.64,395.921,398.216,399.304,403.52,408.662,411.467,414.153,418.344,422.56,427.702,431.893,436.058,439.339,441.634,442.728,447.743,451.024,456.167,460.366,464.089,466.418,468.713,469.801,472.665,474.96000000000004,476.048,478.913,483.928,489.07,491.365,492.453,497.596,502.186,506.376,508.671,509.759,516.279,520.869,524.592,529.607,531.9019999999999,532.99,537.996,543.156,547.372,550.653,558.116" svgx:width="0.27,0.27,0.55,0.33,0.54,0.39,0.27,0.55,0.5,0.61,0.33,0.32,0.49,0.5,0.61,0.49,0.49,0.39,0.27,0.55,0.59,0.39,0.61,0.49,0.44,0.27,0.27,0.55,0.34,0.27,0.55,0.34,0.59,0.61,0.27,0.55,0.61,0.54,0.49,0.27,0.55,0.77,0.54,0.44,0.59,0.27,0.55,0.59,0.61,0.5,0.39,0.88,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">, for anticancer drugs. J Jpn Soc Hosp Pharm </text>
  </g>
  <g begin="text">
   <text y="182.721" x="333.45,338.117,342.783,347.45,352.116,354.445,359.112,363.778,366.107,370.774,375.44,380.107,382.895,387.561,389.89,392.219,395.033,397.719,402.861,405.19,408.055,412.271,417.286,421.502,426.644,430.809,434.532,438.697,441.511" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.27,0.27,0.33,0.32,0.61,0.27,0.34,0.5,0.59,0.5,0.61,0.49,0.44,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2012;48:441‑4. (in Japanese).</text>
  </g>
  <g begin="text">
   <text y="194.338" x="315.0,319.667,324.333,326.662,328.957,333.453,339.973,344.189,351.652,355.868,358.452,364.326,366.655,369.239,375.758,378.444,381.725,385.941,390.718,394.934,397.739,401.955,406.466,410.631,413.215,421.086,423.415,425.999,432.519,436.735,441.243,445.459,450.601,453.287,457.01,462.17,464.856,467.44,472.582,474.911,477.495,482.02,486.236,491.378,495.594,500.103,504.319,506.903,512.045,514.374,516.958,523.478,527.694,531.417,536.576,539.262,544.277,548.493,551.077,555.763,558.092" svgx:width="0.55,0.55,0.27,0.27,0.55,0.77,0.5,0.88,0.5,0.27,0.69,0.27,0.27,0.77,0.32,0.39,0.5,0.56,0.5,0.33,0.5,0.55,0.49,0.27,0.93,0.27,0.27,0.77,0.5,0.55,0.5,0.61,0.32,0.44,0.61,0.32,0.27,0.61,0.27,0.27,0.66,0.5,0.61,0.5,0.55,0.5,0.27,0.61,0.27,0.27,0.77,0.5,0.44,0.61,0.32,0.59,0.5,0.27,0.66,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">28. Hama K, Hirabatake M, Nakanishi S, Tanaka S, Hashida T. </text>
  </g>
  <g begin="text">
   <text y="204.538" x="333.45,338.975,344.041,348.113,349.762,353.833,358.338,362.461,365.053,370.102,374.225,376.936,379.529,384.025,389.074,390.723,395.219,397.931,399.58,403.677,408.173,415.543,420.464,423.652,427.723,432.789,436.861,441.91,445.539,448.132,452.637,456.708,458.357,462.454,466.951,472.0,477.049,479.76,483.832,487.019,494.389,498.46,502.583,506.212,511.261,514.449,518.52,522.15,523.799,526.51,531.007,532.656,535.843,539.915,544.836,549.885,553.982,558.149" svgx:width="0.66,0.61,0.49,0.27,0.49,0.54,0.5,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.54,0.33,0.27,0.49,0.54,0.88,0.59,0.39,0.49,0.61,0.49,0.61,0.44,0.32,0.54,0.49,0.27,0.49,0.54,0.61,0.61,0.33,0.49,0.39,0.88,0.49,0.5,0.44,0.61,0.39,0.49,0.44,0.27,0.33,0.54,0.27,0.39,0.49,0.59,0.61,0.49,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">The evaluation of comprehensive countermeasures to reduce </text>
  </g>
  <g begin="text">
   <text y="214.738" x="333.45,337.904,341.959,346.013,351.02,355.899,359.979,362.648,365.198,369.652,374.658,378.738,381.288,382.801,386.683,391.213,396.092,400.546,404.133,409.14,412.285,416.314,417.827,420.496,424.95,426.463,430.543,435.549,438.218,440.768,444.823,448.903,453.909,457.964,461.993,465.138,466.651,471.53,474.675,479.681,483.744,487.331,488.844,493.723,498.73,501.875,504.425,509.431,513.494,515.007,519.886,523.031,527.06,531.939,536.019,539.164,543.244,545.913,548.463,552.917,558.06" svgx:width="0.54,0.49,0.49,0.61,0.59,0.5,0.33,0.32,0.54,0.61,0.5,0.32,0.27,0.49,0.55,0.59,0.54,0.44,0.61,0.39,0.49,0.27,0.33,0.54,0.27,0.5,0.61,0.33,0.32,0.49,0.5,0.61,0.49,0.49,0.39,0.27,0.59,0.39,0.61,0.49,0.44,0.27,0.59,0.61,0.39,0.32,0.61,0.49,0.27,0.59,0.39,0.49,0.59,0.5,0.39,0.5,0.33,0.32,0.54,0.61,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">occupational exposure to anticancer drugs during preparation </text>
  </g>
  <g begin="text">
   <text y="224.938" x="333.45,338.321,344.118,349.787,352.082,354.08,358.95,364.62,372.737,376.078,381.875,385.215,389.593,393.052,396.988,401.858,405.318,408.658,413.903,419.7,422.683,424.978,426.976,430.495,436.164,441.961,444.25600000000003,446.254,449.773,452.06800000000004,454.065,459.726,465.54,470.411,474.346,482.464,484.759,486.756,493.93,498.75,503.62,506.961,510.42,516.234,518.529,520.527,526.902,531.772,535.708,540.527,542.822,544.82,550.617,555.462,558.148" svgx:width="0.5,0.61,0.59,0.27,0.55,0.5,0.59,0.88,0.32,0.61,0.32,0.44,0.33,0.39,0.5,0.33,0.32,0.54,0.61,0.27,0.27,0.55,0.34,0.59,0.61,0.27,0.55,0.34,0.27,0.55,0.59,0.61,0.5,0.39,0.88,0.27,0.55,0.77,0.49,0.5,0.32,0.33,0.61,0.27,0.55,0.67,0.5,0.39,0.49,0.27,0.55,0.61,0.49,0.32,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">and administration. Jpn J Pharm Health Care Sci </text>
  </g>
  <g begin="text">
   <text y="235.138" x="333.45,338.117,342.783,347.45,352.116,354.445,359.112,363.778,366.107,370.774,375.44,380.107,382.895,387.561,392.228,394.557,396.886,399.699,402.385,407.528,409.857,412.721,416.937,421.952,426.168,431.311,435.476,439.692,443.415,447.58,450.393" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27,0.27,0.33,0.32,0.61,0.27,0.34,0.5,0.59,0.5,0.61,0.49,0.5,0.44,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2013;39:700‑10. (in Japanease).</text>
  </g>
  <g begin="text">
   <text y="246.755" x="315.0,319.667,324.333,326.662,328.957,333.453,337.977,342.142,345.423,350.566,353.252,355.938,358.433,364.307,366.636,369.126,375.671,380.179,384.395,386.732,389.418,396.881,401.097,403.588,410.107,412.436,414.927,421.446,425.662,430.172,434.388,436.725,439.411,446.874,451.09,453.581,458.25,460.579,463.069,468.212,472.428,475.233,479.398,482.203,486.801,489.298,493.463,498.061,502.277,504.963,510.106,514.322,517.127,519.813,524.403,529.545,532.042,536.632,539.437,541.927,547.07,551.235,558.103" svgx:width="0.55,0.55,0.27,0.27,0.55,0.66,0.49,0.39,0.61,0.32,0.32,0.27,0.69,0.27,0.27,0.77,0.55,0.5,0.28,0.32,0.88,0.5,0.27,0.77,0.27,0.27,0.77,0.5,0.55,0.5,0.28,0.32,0.88,0.5,0.27,0.68,0.27,0.27,0.61,0.5,0.33,0.49,0.33,0.54,0.27,0.49,0.54,0.5,0.32,0.61,0.5,0.33,0.32,0.54,0.61,0.27,0.54,0.33,0.27,0.61,0.49,0.81,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">29. Teruii K, Okajima H, Nakajima Y. Safety evaluation of new </text>
  </g>
  <g begin="text">
   <text y="256.955" x="333.45,337.564,342.605,345.308,347.892,351.98,356.094,361.135,365.223,369.286,372.465,374.11,378.198,383.256,387.319,394.68,399.168,401.871,406.928,410.991,414.17,418.284,423.197,427.694,429.338,433.452,438.365,445.726,448.31,453.351,455.935,459.556,462.259,465.438,469.552,472.255,474.839,479.327,484.368,486.012,489.633,494.13,497.751,500.454,504.517,511.878,513.522,517.67,519.315,524.934,529.422,536.783,541.696,545.81,548.989,553.052,558.065" svgx:width="0.5,0.61,0.33,0.32,0.49,0.5,0.61,0.49,0.49,0.39,0.27,0.49,0.61,0.49,0.88,0.54,0.33,0.61,0.49,0.39,0.5,0.59,0.54,0.27,0.5,0.59,0.88,0.32,0.61,0.32,0.44,0.33,0.39,0.5,0.33,0.32,0.54,0.61,0.27,0.44,0.54,0.44,0.33,0.49,0.88,0.27,0.5,0.27,0.67,0.54,0.88,0.59,0.5,0.39,0.49,0.59,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">anticancer chemotherapy administration system – Compared </text>
  </g>
  <g begin="text">
   <text y="267.155" x="333.45,336.255,340.845,343.212,346.017,351.177,355.342,357.713,360.994,365.159,368.882,374.025,376.711,379.516,383.239,385.605,388.41,391.691,396.281,403.744,406.111,410.327,412.695,415.5,420.09,423.371,430.834,434.999,438.28,440.651,444.374,447.179,452.322,457.337,461.196,463.525,465.891,468.756,473.771,478.913,481.278,484.142,486.508,492.228,496.444,501.587,505.777,509.942,513.223,515.595,521.315,526.475,530.64,538.103,542.693,545.498,550.657,554.822,558.103" svgx:width="0.33,0.54,0.27,0.33,0.61,0.49,0.27,0.39,0.49,0.44,0.61,0.32,0.33,0.44,0.27,0.33,0.39,0.54,0.88,0.27,0.5,0.27,0.33,0.54,0.39,0.88,0.49,0.39,0.27,0.44,0.33,0.61,0.59,0.54,0.27,0.27,0.34,0.59,0.61,0.27,0.34,0.27,0.67,0.5,0.61,0.49,0.49,0.39,0.27,0.67,0.61,0.49,0.88,0.54,0.33,0.61,0.49,0.39,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">to the results from a former study. Jpn J Cancer Chemother </text>
  </g>
  <g begin="text">
   <text y="277.355" x="333.45,338.117,342.783,347.45,352.116,354.445,359.112,363.778,366.107,370.774,375.44,380.107,384.773,387.561,392.228,394.557,397.37,400.056,405.199,407.528,410.392,414.608,419.623,423.839,428.982,433.147,436.87,441.035,443.848" svgx:width="0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.55,0.33,0.55,0.27,0.33,0.32,0.61,0.27,0.34,0.5,0.59,0.5,0.61,0.49,0.44,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">2011;38:1483‑7 (in Japanese).</text>
  </g>
  <g begin="text">
   <text y="288.973" x="315.0,319.667,324.333,326.662,328.957,333.453,339.152,341.838,344.524,347.21,351.426,354.707,357.393,362.535,365.221,366.967,374.838,377.167,378.913,384.999,389.589,397.052,399.738,404.881,407.567,411.757,414.443,416.189,421.119,423.448,425.195,430.201,432.887,437.078,441.268,443.954,449.097,451.783,456.925,459.611,461.357,466.967,469.296,471.042,474.99,479.206,482.011,484.697,488.896,493.486,498.628,501.314,503.06,508.781,511.11,512.855,519.179,526.642,531.419,534.7,539.29,543.489,546.175,547.922,555.793,558.122" svgx:width="0.55,0.55,0.27,0.27,0.55,0.71,0.32,0.32,0.32,0.5,0.39,0.32,0.61,0.32,0.27,0.93,0.27,0.27,0.72,0.54,0.88,0.32,0.61,0.32,0.49,0.32,0.27,0.58,0.27,0.27,0.59,0.32,0.49,0.49,0.32,0.61,0.32,0.61,0.32,0.27,0.66,0.27,0.27,0.58,0.5,0.33,0.32,0.49,0.54,0.61,0.32,0.27,0.67,0.27,0.27,0.74,0.88,0.56,0.39,0.54,0.49,0.32,0.27,0.93,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">30. Villarini M, Dominici L, Piccinini R, Fatigoni C, Ambrogi M, </text>
  </g>
  <g begin="text">
   <text y="299.173" x="333.45,339.154,344.279,347.543,350.331,353.0,354.725,360.786,363.098" svgx:width="0.67,0.61,0.39,0.33,0.32,0.27,0.71,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Curti G, </text>
  </g>
  <g begin="text">
   <text y="299.173" x="364.817,368.948,371.473,373.198,378.001" svgx:width="0.49,0.3,0.27,0.57,0.29" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Italic;font-size:8.5px;stroke:none;">et al</text>
  </g>
  <g begin="text">
   <text y="299.173" x="380.459,382.771,384.496,390.803,394.509,398.215,402.363,406.069,409.775,417.221,421.369,426.495,429.283,431.008,435.581,438.369,440.095,445.093,448.357,451.026,458.472,462.671,465.935,469.777,472.089,473.814,478.237,482.886,485.555,490.553,494.752,497.54,500.209,504.791,508.939,510.664,514.863,519.989,524.987,526.712,530.711,535.209,539.382,542.051,545.757,548.426,552.999,558.141" svgx:width="0.27,0.27,0.74,0.44,0.44,0.49,0.44,0.44,0.88,0.49,0.61,0.33,0.27,0.54,0.33,0.27,0.59,0.39,0.32,0.88,0.5,0.39,0.54,0.27,0.27,0.54,0.55,0.32,0.59,0.5,0.33,0.32,0.54,0.49,0.27,0.5,0.61,0.59,0.27,0.49,0.55,0.49,0.32,0.44,0.32,0.54,0.61,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">. Assessment of primary, oxidative and excision </text>
  </g>
  <g begin="text">
   <text y="309.373" x="333.45,336.995,341.423,346.697,351.177,354.126,357.671,362.099,367.374,369.66900000000004,371.13,377.476,384.259,390.846,393.141,394.603,399.882,404.361,412.088,416.567,421.03,425.458,427.75300000000004,429.215,432.165,437.571,439.86600000000004,441.328,446.751,451.604,455.591,460.869,463.819,466.887,471.367,474.316,476.611,478.073,483.347,487.776,491.32,495.307,500.16,505.566,510.972,515.401,518.351,520.646,522.108,527.531,532.01,537.416,542.695,545.644,548.594,554.0,558.2" svgx:width="0.39,0.49,0.59,0.5,0.32,0.39,0.49,0.59,0.27,0.55,0.72,0.77,0.74,0.27,0.55,0.59,0.5,0.88,0.5,0.49,0.49,0.27,0.55,0.32,0.61,0.27,0.55,0.61,0.54,0.44,0.59,0.32,0.33,0.5,0.32,0.27,0.55,0.59,0.49,0.39,0.44,0.54,0.61,0.61,0.49,0.32,0.27,0.55,0.61,0.5,0.61,0.59,0.32,0.32,0.61,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">repaired DNA damage in hospital personnel handling </text>
  </g>
  <g begin="text">
   <text y="319.573" x="333.45,337.666,342.809,345.613,348.299,353.442,357.607,362.197,367.212,369.898,374.114,377.837,380.642,383.328,387.518,389.848,394.863,398.144,403.286,407.485,411.208,413.537,415.866,423.737,428.88,431.685,435.901,440.1,444.265,449.407,453.572,457.295,459.981,463.704,466.033,470.7,475.366,480.033,484.699,487.028,491.695,496.361,498.69,503.357,508.023,512.69,515.478,520.144,524.811" svgx:width="0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27,0.59,0.39,0.61,0.49,0.44,0.27,0.27,0.93,0.61,0.33,0.5,0.49,0.49,0.61,0.49,0.44,0.32,0.44,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">antineoplastic drugs. Mutagenesis 2011;26:359‑69.</text>
  </g>
  <g begin="text">
   <text y="331.19" x="315.0,319.667,324.333,326.662,328.957,333.453,339.973,345.115,350.13,354.296,358.495,362.66,365.941,368.311,374.831,377.16,379.523,384.997,389.213,392.936,397.152,400.433,404.649,409.791,412.16,418.68,421.009,423.372,428.941,433.157,436.438,440.161,442.524,448.848,451.177,453.54,459.617,464.76,468.95,471.313,477.399,479.728,482.091,488.415,492.138,495.861,500.026,503.749,507.472,514.935,519.1,524.243,527.048,529.417,534.007,536.812,539.175,545.261,551.78,558.104" svgx:width="0.55,0.55,0.27,0.27,0.55,0.77,0.61,0.59,0.49,0.49,0.49,0.39,0.27,0.77,0.27,0.27,0.64,0.5,0.44,0.5,0.39,0.5,0.61,0.27,0.77,0.27,0.27,0.69,0.5,0.39,0.44,0.27,0.74,0.27,0.27,0.71,0.61,0.49,0.27,0.72,0.27,0.27,0.74,0.44,0.44,0.49,0.44,0.44,0.88,0.49,0.61,0.33,0.27,0.54,0.33,0.27,0.72,0.77,0.74,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">31. Undeger U, Basaran N, Kars A, Güç D. Assessment of DNA </text>
  </g>
  <g begin="text">
   <text y="341.39" x="333.45,338.592,342.936,350.526,354.87,359.197,363.489,365.784,367.11,369.924,375.194,377.48900000000003,378.815,384.085,389.354,392.763,396.613,400.906,404.757,407.052,408.378,413.664,418.008,423.278,428.42,431.234,434.047,439.317,443.644,445.939,447.265,451.608,456.878,459.811,462.624,467.894,472.187,476.904,482.047,484.86,489.204,493.054,495.987,498.8,503.118,505.413,506.739,511.882,515.29,520.56,524.887,528.737,531.0319999999999,532.358,537.263,541.989,544.284,545.61,548.542,553.829,557.996" svgx:width="0.59,0.5,0.88,0.5,0.49,0.49,0.27,0.55,0.32,0.61,0.27,0.55,0.61,0.61,0.39,0.44,0.49,0.44,0.27,0.55,0.61,0.5,0.61,0.59,0.32,0.32,0.61,0.49,0.27,0.55,0.5,0.61,0.33,0.32,0.61,0.49,0.54,0.59,0.32,0.5,0.44,0.33,0.32,0.49,0.27,0.55,0.59,0.39,0.61,0.49,0.44,0.27,0.55,0.56,0.54,0.27,0.55,0.33,0.61,0.49,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">damage in nurses handling antineoplastic drugs by the </text>
  </g>
  <g begin="text">
   <text y="351.59" x="333.45,337.666,340.352,344.86,349.076,351.762,354.448,359.59,363.755,366.084,371.805,378.35,386.221,391.295,396.914,399.243,403.459,407.182,410.905,415.121,418.981,421.31,423.639,431.51,436.653,439.458,443.674,446.479,448.808,454.268,458.433,462.156,464.485,469.152,473.818,478.485,483.151,485.48,490.147,494.813,499.48,501.809,506.475,511.142,515.808,518.596,523.263,527.929" svgx:width="0.5,0.32,0.55,0.5,0.32,0.32,0.61,0.49,0.27,0.67,0.77,0.93,0.6,0.66,0.27,0.5,0.44,0.44,0.5,0.54,0.27,0.27,0.93,0.61,0.33,0.5,0.33,0.27,0.66,0.49,0.44,0.27,0.55,0.55,0.55,0.55,0.27,0.55,0.55,0.55,0.27,0.55,0.55,0.55,0.33,0.55,0.55,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">alkaline COMET assay. Mutat Res 1999;439:277‑85.</text>
  </g>
  <g begin="text">
   <text y="363.207" x="315.0,319.665,324.33,326.662,328.957,333.453,336.335,341.654,347.392,353.928,356.308,359.19,364.349,372.237,378.799,381.179,383.913,390.108,395.267,400.291,406.853,409.148,410.363,413.245,417.852,420.555,425.714,428.536,430.831,432.047,438.141,443.301,446.004,451.036,455.218,457.921,460.624,465.783,469.965,473.705,476.0,477.216,480.038,484.645,487.943,490.238,491.453,496.613,500.846,503.668,507.85,510.14500000000004,511.36,517.897,522.13,527.289,532.321,535.024,537.727,542.887,547.103,549.3979999999999,550.613,555.22,558.026" svgx:width="0.55,0.55,0.27,0.27,0.55,0.34,0.61,0.67,0.77,0.28,0.34,0.61,0.93,0.77,0.28,0.34,0.74,0.61,0.59,0.77,0.27,0.55,0.34,0.54,0.32,0.61,0.33,0.27,0.55,0.71,0.61,0.32,0.59,0.49,0.32,0.32,0.61,0.49,0.44,0.27,0.55,0.33,0.54,0.39,0.27,0.55,0.61,0.5,0.33,0.49,0.27,0.55,0.77,0.5,0.61,0.59,0.32,0.32,0.61,0.49,0.27,0.55,0.54,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">32. JSCN/JSMO/JASPO Joint Guidelines for Safe Handling of </text>
  </g>
  <g begin="text">
   <text y="373.407" x="333.45,339.298,343.642,348.911,353.229,357.522,360.931,363.226,364.552,370.4,375.686,379.979,387.57,392.287,395.22,400.507,404.799,408.208,412.551,417.694,422.42,424.71500000000003,426.041,432.254,435.663,440.933,445.259,449.11,451.566,453.861,455.187,460.885,465.228,470.498,474.791,480.078,484.421,487.83,492.173,494.468,495.794,501.642,506.36,508.816,511.273,513.568,514.894,519.951,522.884,528.026,530.483,532.939,535.2339999999999,536.56,541.354,546.148,550.942,555.736,558.064" svgx:width="0.67,0.5,0.61,0.49,0.49,0.39,0.27,0.55,0.67,0.61,0.49,0.88,0.54,0.33,0.61,0.49,0.39,0.5,0.59,0.54,0.27,0.55,0.72,0.39,0.61,0.49,0.44,0.27,0.27,0.55,0.69,0.5,0.61,0.49,0.61,0.5,0.39,0.5,0.27,0.55,0.67,0.54,0.27,0.27,0.27,0.55,0.58,0.33,0.59,0.27,0.27,0.27,0.55,0.55,0.55,0.55,0.55,0.27,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">Cancer Chemotherapy Drugs. Kanehara Co., Ltd.; 2015. </text>
  </g>
  <g begin="text">
   <text y="383.607" x="333.45,338.465,340.794,343.123,347.79,352.456,354.785,357.114,359.928,362.614,367.756,370.085,372.95,377.166,382.181,386.397,391.539,395.704,399.427,403.592,406.406" svgx:width="0.59,0.27,0.27,0.55,0.55,0.27,0.27,0.33,0.32,0.61,0.27,0.34,0.5,0.59,0.5,0.61,0.49,0.44,0.49,0.33,0.27" style="fill:rgb(23,22,21);font-family:ZapfElliptical711BT-Roman;font-size:8.5px;stroke:none;">p. 45. (in Japanese).</text>
  </g>
 </g>
</svg>
